Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark
July 15, 2020 09:00 ET
|
Guardion Health Sciences, Inc.
The Only Computer Vision Testing Device to Combine Standardized Contrast Sensitivity Testing with a Full Suite of Clinical Vision Tests San Diego, California, July 15, 2020 (GLOBE NEWSWIRE) --...
Guardion Health Sciences Announces Submission of Patent Application for Treatment of Certain Underlying Conditions Related to Eye Disease
July 08, 2020 08:45 ET
|
Guardion Health Sciences, Inc.
Patent Application Will Add to Guardion’s Intellectual Property Portfolio San Diego, California, July 08, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”)...
Guardion Health Sciences Names Dr. David Evans as Interim President and Interim Chief Executive Officer
June 15, 2020 16:20 ET
|
Guardion Health Sciences, Inc.
San Diego, California, June 15, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced today that its Board of Directors has appointed Dr....
Guardion Health Sciences Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 14, 2020 07:00 ET
|
Guardion Health Sciences, Inc.
— 40% increase in medical foods revenue in the first quarter compared to the same period last year — Launch of immuno-supportive/antioxidant complex, acuMMUNE™ — Growing portfolio of synergistic...
Lumega-Z® Demonstrates Superiority in a Head-to-Head Study Showing Better Bioavailability of Carotenoids and Restoring Macular Pigment Density
May 12, 2020 07:05 ET
|
Guardion Health Sciences, Inc.
-- First study to provide a head-to-head comparison of two commercially available supplements with regard to the changes in serum levels of carotenoids, visual function and macular pigment optical...
Guardion Health Sciences to Present at the April 2020 Virtual Investor Summit
April 15, 2020 09:05 ET
|
Guardion Health Sciences, Inc.
– Presentation with live audio webcast on Wednesday, April 22 at 1:30 PM ET, immediately followed by an interactive Q&A session – San Diego, California, April 15, 2020 (GLOBE NEWSWIRE)...
Guardion Health Sciences Receives $3.5 Million from Exercise of Warrants
March 06, 2020 08:05 ET
|
Guardion Health Sciences, Inc.
San Diego, California, March 06, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences company that develops, formulates,...
Guardion® Appoints Experienced Executive to Lead Development and Expansion of Recently-Acquired NutriGuard Business Line
January 07, 2020 11:02 ET
|
Guardion Health Sciences, Inc.
San Diego, California, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a leader in the field of ocular health technologies and...
Guardion Health Sciences, Inc. Reports Results for the Three and Nine Months Ended September 30, 2019
November 14, 2019 07:00 ET
|
Guardion Health Sciences, Inc.
Results Highlighted by 33% Increase in Revenues for Guardion’s Flagship Medical Food Lumega-Z® San Diego, CA, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the...
Guardion® Receives approval from USPTO for expanded claims for its Proprietary Medical Device, the MAPCAT SF
October 23, 2019 07:00 ET
|
Guardion Health Sciences, Inc.
San Diego, California, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced that it has received approval from the USPTO for...